Showing results (71-80 of 132) with videos related to
Sort By:
Pageof 14
Medical Oncology (Northwood, London, England)|January 25, 2011
Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancerMotohiro Tamiya, Hidekazu Suzuki, Masashi Kobayashi, et al.Journal of Thoracic Disease|February 24, 2016
Chemotherapy for patients with advanced lung cancer receiving long-term oxygen therapyManabu Hayama, Hidekazu Suzuki, Takayuki Shiroyama, et al.Asia-Pacific Journal of Clinical Oncology|December 23, 2016
Afatinib successfully treated leptomeningeal metastasis during erlotinib treatment in a patient with EGFR-mutant (Exon18:G719S) lung adenocarcinoma as a second-line chemotherapyMotohiro Tamiya, Takayuki Shiroyama, Takashi Nishihara, et al.Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|September 4, 2007
[A case of prostatic adenocarcinoma clinically presenting as supraclavicular and mediastinal lymphadenopathy]Kazuyuki Tsujino, Sinji Sasada, Kunimitsu Kawahara, et al.Anticancer Research|December 27, 2011
Hypersensitivity reactions associated with platinum-containing antineoplastic agents for thoracic malignanciesMotohiro Tamiya, Hanako Kuhara, Tomonori Hirashima, et al.Anticancer Research|January 31, 2012
A retrospective study of chemotherapy with and without pemetrexed in malignant pleural mesotheliomaMasayoshi Higashiguchi, Hidekazu Suzuki, Tomonori Hirashima, et al.Internal Medicine (Tokyo, Japan)|August 28, 2018
Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma with G719S, S768I, and T790M MutationsShingo Nasu, Takayuki Shiroyama, Satomu Morita, et al.Journal of Thoracic Disease|May 11, 2016
A heterochronic genetic change from an EGFR mutation to an ALK rearrangement in a patient with lung adenocarcinoma: a case reportTakayuki Shiroyama, Motohiro Tamiya, Manabu Hayama, et al.Internal Medicine (Tokyo, Japan)|August 2, 2016
Endoscopic Bronchial Occlusion with Silicon Spigots for the Treatment of an Alveolar-pleural Fistula during Anti-tuberculosis Therapy for Tuberculous EmpyemaTakashi Nishihara, Manabu Hayama, Norio Okamoto, et al.Medical Oncology (Northwood, London, England)|July 16, 2010
Prognosis of small-cell lung cancer since the introduction of amrubicinHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.Pageof 14